Liabilities / Assets
19th percentile
Higher debt load relative to assets than 19% of similar nonprofits.
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
19th percentile
Higher debt load relative to assets than 19% of similar nonprofits.
Liabilities / Revenue
43rd percentile
Higher debt load relative to revenue than 43% of similar nonprofits.
Net Margin
1st percentile
Higher net margin than 1% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
3rd percentile
Faster asset growth than 3% of similar nonprofits.
Revenue Growth
3rd percentile
Faster revenue growth than 3% of similar nonprofits.
Assets
Down$5,328,300
Down $1,845,859 (-26%) from 2014
Net Assets
Down$5,252,763
Down $1,806,673 (-26%) from 2014
Liabilities
Down$75,537
Down $39,186 (-34%) from 2014
Revenue
Down$552,106
Down $1,037,030 (-65%) from 2014
Expenses
Down$2,358,779
Down $559,558 (-19%) from 2014
Net Income
Down-$1,806,673
Down $477,472 (-36%) from 2014
This 2015 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
Charley's fund's singular mission is to support the development of treatments and a cure for duchenne muscular dystrophy (dmd). We identify and direct funding to the most compelling research and treatment programs related to dmd and, (cont. On sch. O.)
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2015 • Form 990Summary only. Only limited summary data is available for this year.